The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
János L. Tanyi(Penn Center for AIDS Research), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), E. Neely Atkinson(The University of Texas Health Science Center at Houston), Andrew J. Morris(Central Arkansas Veterans Healthcare System), Robert A. Newman(The University of Texas MD Anderson Cancer Center), Xianjun Fang(Virginia Commonwealth University), Judith K. Wolf(The University of Texas Health Science Center at Houston), Yutaka Hasegawa(Iwate Medical University), Nelly Auersperg(University of Central Florida), Ruth LaPushin(The University of Texas MD Anderson Cancer Center), Edward Felix(Texas Medical Center), Yury J. Sigal(University of North Carolina at Chapel Hill)
PubMed
March 1, 2003
Cited by 143
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k